Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies
Sonal V. Bhujbal, Biplob Mitra, Uday K. Jain, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2505-2536
Open Access | Times Cited: 339

Showing 1-25 of 339 citing articles:

Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization
Srushti Tambe, Divya Jain, Saikishore Meruva, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2203-2203
Open Access | Times Cited: 75
Advances in the development of amorphous solid dispersions: The role of polymeric carriers
Jie Zhang, Minshan Guo, Minqian Luo, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 100834-100834
Open Access | Times Cited: 64
Opportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: A novel delivery system perspective
Dan Yuan, Yujie Guo, Feiyan Pu, et al.
Food Chemistry (2023) Vol. 430, pp. 137115-137115
Closed Access | Times Cited: 42
Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023
Dana E. Moseson, Tran Trong Bien, Bharathi Karunakaran, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100259-100259
Open Access | Times Cited: 32
Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs
Isaïe Nyamba, Charles B Sombié, Moussa Yabré, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024), pp. 114513-114513
Closed Access | Times Cited: 21
Leveraging Crystalline and Amorphous States of a Metal‐Organic Complex for Transformation of the Photosalient Effect and Positive‐Negative Photochromism
Yu‐Juan Ma, Guowei Xiao, Xiaoyu Fang, et al.
Angewandte Chemie International Edition (2022) Vol. 62, Iss. 11
Closed Access | Times Cited: 54
Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance
Qin Shi, Haibiao Chen, Yanan Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1747-1747
Open Access | Times Cited: 43
TPU-based antiplatelet cardiovascular prostheses prepared using fused deposition modelling
Juan Domínguez‐Robles, Emilia Utomo, Victoria A. Cornelius, et al.
Materials & Design (2022) Vol. 220, pp. 110837-110837
Open Access | Times Cited: 42
Current Trends on Solid Dispersions: Past, Present, and Future
Ruba Malkawi, Walla I. Malkawi, Yahia Al-Mahmoud, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 41
Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers
Hanh Thuy Nguyen, Tu Van Duong, Lynne S. Taylor
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1681-1695
Open Access | Times Cited: 32
Three Potential Elements of Developing Nerve Guidance Conduit for Peripheral Nerve Regeneration
Chaoying Zhang, Jiaxing Gong, Jingyu Zhang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 40
Closed Access | Times Cited: 27
Insights into drug loading techniques with mesoporous silica nanoparticles: Optimization of operating conditions and assessment of drug stability
Ali H. Khalbas, Talib M. Albayati, Noori M. Cata Saady, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105698-105698
Closed Access | Times Cited: 15
Amorphous Solubility Advantage: Theoretical Considerations, Experimental Methods, and Contemporary Relevance
Keisuke Ueda, Dana E. Moseson, Lynne S. Taylor
Journal of Pharmaceutical Sciences (2024) Vol. 114, Iss. 1, pp. 18-39
Closed Access | Times Cited: 15
Solubilization techniques used for poorly water-soluble drugs
Bing Xie, Yaping Liu, Xiaotong Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4683-4716
Open Access | Times Cited: 14
Understanding the Interaction of Thermal, Rheological, and Mechanical Parameters Critical for the Processability of Polyvinyl Alcohol-Based Systems during Hot Melt Extrusion
Florian Heß, Thomas Kipping, Werner Weitschies, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 472-472
Open Access | Times Cited: 12
Sustained release polymer and surfactant based solid dispersion of andrographolide exhibited improved solubility, dissolution, pharmacokinetics, and pharmacological activity
Syed Assim Haq, Gourav Paudwal, Nagma Banjare, et al.
International Journal of Pharmaceutics (2024) Vol. 651, pp. 123786-123786
Closed Access | Times Cited: 10
In Vitro and In Vivo testing of 3D-Printed Amorphous Lopinavir Printlets by Selective Laser Sinitering: Improved Bioavailability of a Poorly Soluble Drug
Canberk Kayalar, Nada A. Helal, Eman M. Mohamed, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 1
Closed Access | Times Cited: 9
Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental–Theoretical Study
Luís Henrique Silva Queiroz, Ranna S. Barros, Francisco F. de Sousa, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1272-1284
Closed Access | Times Cited: 8
Pediatric Formulations Developed by Extrusion-Based 3D Printing: From Past Discoveries to Future Prospects
Veronica Ianno, Sarah Vurpillot, Sylvain Prillieux, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 441-441
Open Access | Times Cited: 8
Carrier-Free Nanodrugs: From Bench to Bedside
Fang Fang, Xiaoyuan Chen
ACS Nano (2024) Vol. 18, Iss. 35, pp. 23827-23841
Closed Access | Times Cited: 8
Creation of Long-Term Physical Stability of Amorphous Solid Dispersions N-Butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide, Resistant to Recrystallization Caused by Exposure to Moisture
Владимир Борисович Маркеев, Evgenia V. Blynskaya, К. В. Алексеев, et al.
Materials (2025) Vol. 18, Iss. 1, pp. 203-203
Open Access | Times Cited: 1
Formation of drug–drug salt crystals and co-amorphous forms of levofloxacin and 4-aminosalicylic acid for pulmonary applications
Hiroshi Ueda, Jun Yee Tse, Tetsuya Miyano, et al.
RSC Pharmaceutics (2025)
Open Access | Times Cited: 1
Variable pore size of mesoporous silica in improving physical stability and oral bioavailability of insoluble drugs
Wanhao Qi, Jinghao Chen, Shiqiao Rui, et al.
International Journal of Pharmaceutics (2025), pp. 125394-125394
Closed Access | Times Cited: 1
Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca
Akosua B. Anane‐Adjei, Esther Jacobs, Samuel C. Nash, et al.
International Journal of Pharmaceutics (2021) Vol. 614, pp. 121387-121387
Closed Access | Times Cited: 51
Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five
Sven Stegemann, Chris Moreton, Sami Svanbäck, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103344-103344
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top